LEO Pharma Announces FDA Approval of Adbry™ (tralokinumab) as the First and Only Treatment…

…Great Britain, Canada and the United Arab Emirates. BALLERUP, DENMARK–( / ) December 31, 2021 — LEO Pharma A/S, a global … Great Britain, Canada and the United Arab Emirates. About the pivotal ECZTRA 1, 2 and ECZTRA 3 Trials ECZTRA 1 and ECZTRA…